Coronavirus treatments and vaccines – research on 3 types of antivirals and 10 different vaccines is being fast-tracked
Just three months after China first notified the World Health Organization about a deadly new coronavirus, studies of numerous antiviral treatments and potential vaccines are already underway. Never has science advanced so much in such a short period of time to combat an epidemic.
A century ago, on July 26, 1916, a viral disease swept through New York. Within 24 hours, new cases of polio increased by more than 68%. The outbreak killed more than 2,000 people in New York City alone. Across the United States, polio took the lives of about 6,000 people in 1916, leaving thousands more paralyzed.
The coronavirus has ground social, economic and educational exchanges to a halt around the world. For now, public health officials are relying on tools like social distancing to minimize the harm of the virus, but in the long term, a COVID-19 vaccine is the best hope of a return to normalcy.
The COVID-19 pandemic has brought medical supply chains into the spotlight. There has been a national shortage of testing kits, and at least one drug is already unavailable because of the outbreak, though it hasn’t been publicly named.
Could chloroquine treat coronavirus? 5 questions answered about a promising, problematic and unproven use for an antimalarial drug
An Arizona man died, and his wife was hospitalized, after taking a form of chloroquine, which President Trump has touted as an effective treatment for COVID-19.
Why defeating coronavirus in one country isn’t enough – there needs to be a coordinated global strategy
Policymakers in countries where there are severe outbreaks of COVID-19 are doing what they can to slow the spread and “flatten the curve.” But so far, there hasn’t been much global coordination, raising the risk of a second wave of contamination even after individual countries halt the virus’ advance.